MITO-5: Weekly Carboplatin and Paclitaxel as First Line Chemotherapy for Elderly Patients With Ovarian Cancer

NCT00401674 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: carboplatin
DRUG: paclitaxel

Sponsor

National Cancer Institute, Naples